DENTERIC: for people with early Alzheimers

The research project is testing a potential new treatment for adults with Alzheimer's who also have measurable levels of a bacteria called Porphyromonas gingivalis in their saliva. This bacteria may increase the risk of developing Alzheimer's. 

People who meet the following criteria may be eligible to participate: 

• Aged 55 - 85
• A diagnosis of mild cognitive impairment or mild alzheimers dementia
• Have greater than 50% of their own natural teeth 

Participation is for 7 months and involves 3 injections, MRIs, PET scan, and blood tests.